300957.SZ SHZ
Yunnan Botanee Bio-Technology Group Co.LTD
1W: +0.4%
1M: +1.5%
3M: +2.1%
YTD: -32.6%
1Y: -27.4%
3Y: -62.9%
5Y: -86.3%
¥32.70 ($4.88)
+0.39 (+1.21%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$695M
+13.8% ▲
5Y CAGR: +6.2%
Capital Expenditures
$378M
-38.0% ▼
5Y CAGR: +44.0%
Free Cash Flow
$316M
-5.9% ▼
5Y CAGR: -7.0%
Dividends Paid
$263M
+22.6% ▲
Buybacks
$125M
-13.7% ▼
Net Change in Cash
-$338M
+7.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $544M | $864M | $1.1B | $757M | $495M |
| Depreciation & Amort. | $14M | $59M | $93M | $138M | $190M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$151M | $224M | -$347M | -$186M | -$6M |
| Other Non-Cash Items | $24M | $6M | -$27M | -$9M | $16M |
| Operating Cash Flow | $431M | $1.2B | $769M | $610M | $695M |
| — Investing Activities — | |||||
| Capital Expenditures | -$89M | -$271M | -$353M | -$274M | -$378M |
| Acquisitions (Net) | $89M | -$6M | -$7M | -$493M | $0 |
| Investment Purchases | -$760M | -$8.6B | -$6.8B | -$4.9B | -$5.0B |
| Investment Sales | $763M | $6.3B | $7.1B | $5.1B | $4.3B |
| Other Investing | -$89M | $226K | $11K | $62M | $3M |
| Investing Cash Flow | -$86M | -$2.6B | -$18M | -$518M | -$1.1B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$15M | $0 | -$65M | $81M | $527M |
| Stock Repurchased | $0 | -$2.9B | $0 | -$110M | -$125M |
| Dividends Paid | -$101M | -$191M | -$55M | -$339M | -$263M |
| Other Financing | -$5M | $2.8B | -$784K | -$201M | -$87M |
| Financing Cash Flow | -$121M | $2.7B | -$320M | -$458M | $52M |
| Net Change in Cash | $224M | $1.3B | $431M | -$367M | -$338M |
| Cash End of Period | $751M | $2.0B | $2.4B | $2.1B | $1.7B |
| Free Cash Flow | $342M | $882M | $416M | $336M | $316M |